Related Experiment Video

Updated: Jun 12, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.5K

Increasing prostate cancer radiosensitivity by miR-7-5p knockdown of anti-apoptotic genes

Leili Darvish1, Mohammad-Taghi Bahreyni-Toossi2, Seyed Hamid Aghaee-Bakhtiari3

  • 1Mother and Child Welfare Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; Department of Radiology, Faculty of Paramedicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Gene
|September 20, 2024
PubMed

Insights

This study shows that hsa-miR-7-5p can overcome radiation resistance in prostate cancer by suppressing anti-apoptotic genes. This enhances radiosensitivity and increases apoptosis, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Prostate cancer radiotherapy is limited by radiation resistance.
  • Identifying mechanisms to overcome resistance is crucial for improving treatment efficacy.

Purpose of the Study:

  • To investigate the role of hsa-miR-7-5p in overcoming radiation resistance in prostate cancer.
  • To determine if hsa-miR-7-5p can suppress anti-apoptotic genes and enhance radiosensitivity.

Main Methods:

  • Bioinformatic search for anti-apoptotic genes (XIAP, MCL1, REL, BIRC3) targeted by hsa-miR-7-5p.
  • Transfection of hsa-miR-7-5p into prostate cancer cell lines (PC3 and LNCaP).
  • Assessment of radiosensitivity using real-time PCR, clonogenic assay, and annexin V flow cytometry.

Main Results:

  • hsa-miR-7-5p transfection significantly increased apoptosis rates at 0 Gy and 4 Gy compared to control groups.
  • Suppression of anti-apoptotic genes XIAP, MCL1, Birc3, and REL was observed.
  • Enhanced radiosensitivity was demonstrated in PC3 and LNCaP cell lines with increased hsa-miR-7-5p expression.

Conclusions:

  • hsa-miR-7-5p effectively suppresses anti-apoptotic gene expression, promoting apoptosis in prostate cancer cells.
  • Targeting anti-apoptotic genes with hsa-miR-7-5p represents a promising strategy to enhance prostate cancer radiotherapy efficacy.
  • This miRNA plays a key role in regulating apoptosis and could be a therapeutic target.
Keywords:
ApoptosisProstate cancerRadio-sensitivityRadiotherapymiRNA

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K